Company Research Report: IQ Endoscopes Ltd.

Company Overview

• Name: IQ Endoscopes Ltd.

• Mission: To transform the delivery of endoscopy services by eliminating many of the challenges and risks presented by traditional reusable endoscopic technologies. By improving endoscopists' ways of working, the company aims to give them greater flexibility, choice, and control to increase capacity and ultimately save patients’ lives.

• Founded: 2015

• Founder: Dr. Patrick Ward-Booth

• Key People:

• Dr. Patrick Ward-Booth, Co-Founder and Chairman

• Andrew Miller, Co-Founder and Chief Technology Officer

• Matthew Ginn, Chief Executive Officer

• Felicity Sartain, Chief Operations Officer

• Chris Jenkins, Head of Quality, Regulatory & Compliance

• Tom Kahan, Chief Financial Officer

• Headquarters: Chepstow, South Wales

• Number of Employees: Information not available

• Revenue: Information not available

• Notability: Known for creating single-use, high-performance flexible endoscopes designed to be sterile, environmentally friendly, and cost-effective. The company uses unique and patented technology developed through a collaboration between clinical and engineering experts.

Products

• Product Offering: Single-use flexible endoscopes

• Q Vision G-100 Gastroscope:

• Description: The first product to receive regulatory approval, it signifies the company’s strategy to offer sustainable single-use endoscopes.

• Key Features:

• Clinically effective with high image quality and ergonomic handling.

• Single-use design to eliminate reprocessing challenges.

• Environmentally friendly, designed for easy recycling.

• Aimed at reducing patient waiting times and increasing capacity by more than 20%.

Recent Developments

• New Products:

• Launched the first generation Q Vision G-100 Gastroscope, a single-use endoscope.

• Regulatory Approvals:

• Received FDA 510(k) Clearance in December 2023 for the Q Vision G-100 Gastroscope.

• Achieved UKCA regulatory approval in November 2023 for the same product.

• Partnerships and Investments:

• Secured a £5.2m investment from BGF and the Development Bank of Wales to support expansion and technological development.

• Commended by Welsh Secretary David Davies for its growth and innovation in March 2024.

• Product Features Expansion: Committed to expanding the product range to include a full set of GI endoscopes between 2024 and 2025.

Conclusion

IQ Endoscopes Ltd. is leveraging its unique patented technology to revolutionize the endoscopy services market through its innovative single-use endoscope products. Its commitment to addressing global demand and its potential to improve patient outcomes position it as a pivotal player in medical device innovation, with significant advancements in product releases and regulatory milestones achieved recently.